Cytomos secures £4M to advance new approach to cell analysis

Cytomos, an Edinburgh-based life science company that has developed a proprietary new approach to analysing cells, has secured £4 million to scale up market-testing of its technology platform Cytomos Dielectric Spectroscopy (CDS).

Related Keywords

Edinburgh ,City Of ,United Kingdom ,British ,Lindsay Fraser ,Sarah Hardy ,David Rigterink ,Contract Development ,Old College Capital ,British Business Bank ,Cytomos Dielectric Spectroscopy ,Scottish Enterprise ,British Business ,Advanced Therapy ,Medical Products ,